Ivan Tornos
About Ivan Tornos
Ivan Tornos - President and CEO of Zimmer Biomet
Ivan Tornos is the President and CEO of Zimmer Biomet, having joined the company in November 2018 as Group President, Orthopedics. He quickly progressed within the company, becoming the Group President of Global Businesses and the Americas within a year. In March 2021, he was appointed Chief Operating Officer before assuming his current role. Tornos' tenure at Zimmer Biomet has been marked by significant leadership and operational roles, showcasing his expansive expertise in the medical device and healthcare sectors.
Ivan Tornos Education Background
Ivan Tornos holds an MBA from the University of Miami School of Business. He also earned a BBA in Finance and International Marketing and Management from the University of Georgia Terry College of Business. Tornos further expanded his leadership and management skills by completing the Advanced Management Program at Harvard Business School and additional programs at the Cox School of Business of Southern Methodist University. His post-MBA work includes CPD Marketing/Finance at the Wharton School of the University of Pennsylvania.
Ivan Tornos' Career at Becton Dickinson and Company
Before joining Zimmer Biomet, Ivan Tornos served as Worldwide President of the Global Urology, Medical, and Critical Care Division at Becton, Dickinson and Company. Here, he was responsible for overseeing the global operations of these critical business divisions, further solidifying his reputation in the healthcare industry.
Ivan Tornos' Leadership Roles at C.R. Bard
Ivan Tornos spent significant years at C.R. Bard, where he held various positions of increasing responsibility. His most recent role there was President of the Europe, Middle East, and Africa regions. His leadership at C.R. Bard involved managing large-scale operations across diverse markets, demonstrating his capacity to handle complex, multinational business functions.
Ivan Tornos' Industry Contributions and Board Memberships
Ivan Tornos continues to contribute to the healthcare industry through various leadership roles and board memberships. He serves as an independent member of the Board of Directors of global healthcare company PHC Holdings Corporation. His extensive experience in the field makes him a valuable advisor and leader, guiding critical business decisions and strategies.